Top Medical News
Stephen Padilla, 18 hours ago
Awareness of coeliac disease is growing, but the delay in diagnosis remains prolonged for patients without gastrointestinal (GI) symptoms, averaging at 3.5 years, according to a recent study.
Pearl Toh, Yesterday
Indication and demand for genetic testing have increased in recent years, with tests becoming more readily available and affordable, says a leading oncologist at ESMO Asia 2017, highlighting that appreciation of ethical, social, and legal implications of testing and proper test interpretation are important for optimal patient management.
2 days ago
The risk of fatal and nonfatal cardiovascular disease (CVD) is elevated in individuals with histories of gallstone disease (GD), a recent study has found.
Roshini Claire Anthony, 2 days ago

A modified (lower-dose) of XELIRI with or without bevacizumab may be an alternative second-line chemotherapy treatment for patients with metastatic colorectal cancer (CRC), according to results of the noninferiority phase III AXEPT* trial. 

Jairia Dela Cruz, 3 days ago
Cyclosporine is as effective as infliximab in patients with steroid-refractory acute severe ulcerative colitis, having a similar colectomy rate but reduced incidence of serious adverse events, a study from Spain has shown.
6 days ago
Total intravenous anaesthesia with propofol yields better survival compared with volatile anaesthetics (VA) for oesophageal cancer surgery, a recent retrospective observational study has found.
Audrey Abella, 16 Nov 2017
A repeat 2-week course of the antibiotic rifaximin favourably impacts quality of life (QoL) in patients with diarrhoea-predominant irritable bowel syndrome (IBS-D), according to a study.
Special Reports
09 Oct 2017
In this issue of MIMS Gastroenterology Supplement, we bring you clinical updates related to hepatitis B, and also a symposium highlight in conjunction with the launch of tenofovir disoproxil fumarate (Ricovir®; Mylan Laboratories) in Malaysia.  
02 Oct 2017
Last August, the article 'Role of General Practitioners in Early Detection of Inflammatory Bowel Disease' highlighted proper screening and early specialist referral by the general practitioner (GP) as vital components in reducing the burden of inflammatory bowel disease (IBD). This year, the focus is on the role of GPs in co-managing a patient with IBD at the follow-up phase.
29 Sep 2017
Nonalcoholic fatty liver disease (NAFLD), including simple steatosis and nonalcoholic steatohepatitis (NASH), is widely considered as the liver manifestation of the metabolic syndrome. It is a major cause of liver disease worldwide and its prevalence is expected to rise in tandem with the rising prevalence of obesity and diabetes mellitus. Recently, MIMS Doctor spoke to Associate Professor Dr Wah Kheong Chan, a Consultant Physician and Gastroenterologist at the University of Malaya Medical Centre and University of Malaya Specialist Centre, to provide an update on NAFLD, with a particular emphasis on the use of silymarin for the treatment of NASH. Here are the highlights from the interview. 
29 Sep 2017
Constipation is a common disorder which adversely affects the wellbeing and quality of life of patients.1 Recently, MIMS Doctor spoke to Associate Prof Dr Raja Affendi Raja Ali on the landscape of constipation in Malaysia, emphasizing on effective and early management of the condition.
12 Jul 2017
DUKORAL – Inactivated Vibrio cholerae O1 serogroup & recombinant cholera toxin B subunit (WC/rCTB) vaccine (oral) – AJ Biologics
20 Mar 2017
At the recent Asian Pacific Digestive Week (APDW) 2016 held in Kobe, Japan, three prominent international experts shared their views on gastroesophageal reflux disease (GERD) and the challenges of its management.
04 Jan 2017
Recently, randomized controlled trials and guidelines have brought to light the benefits of extending the duration of H. pylori treatment. Below are summaries of guidelines and trials examining the regimens used to manage the infection.
Conference Reports
Jackey Suen, 24 Oct 2017

Virtual hepatic venous pressure gradient (vHVPG), a novel noninvasive approach to assess portal hypertension, is shown to correlate well with the gold-standard invasive method in a recent Chinese study.

Dr. Joseph Delano Fule Robles, 10 Oct 2017

A recent study from China showed that faecal microbiota transplantation (FMT) is effective as a therapeutic option for patients with inflammatory bowel disease (IBD).

Naomi Rodrig, 09 Oct 2017

New endoscopic technologies have improved outcomes for patients with upper gastrointestinal bleeding (UGIB), according to Professor James Lau from the Chinese University of Hong Kong, who reviewed current treatment practices and latest advances at the Asian Pacific Digestive Week (APDW) 2017 held recently in Hong Kong.

Elaine Tan, 04 Oct 2017

Sodium phosphate (NaP) tablets for bowel preparation prior to colonoscopy are safe, better tolerated by patients, and provide equivalent and possibly superior colon cleansing compared with standard polyethylene glycol (PEG) solution, a Korean study has found.

Elaine Tan, 04 Oct 2017

Functional cure of hepatitis B virus (HBV) infection could be possible in the near future with the development of drugs that inhibit HBV replication, recent early-phase clinical studies have shown.

04 Oct 2017
Slideshow: Highlights from the Asia Pacific Digestive Week 2017 (APDW 2017)
Jenny Ng, 04 Oct 2017

Genotypic resistance-guided therapy is no better than traditional empiric therapy for treating patients with refractory Helibacter pylori infection. Researchers found no significant difference in eradication rate between the two strategies when used in the third-line setting.

CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
DOWNLOAD